Expert Consensus on Clinical Diseases Responding Specifically to Traditional Chinese Medicine： Perimenopausal Syndrome
10.13422/j.cnki.syfjx.20242492
- VernacularTitle:中医药临床优势病种探讨——围绝经期综合征
- Author:
Shiwan HU
1
;
Haiyan LIANG
2
;
Kun MA
3
;
Xiaona MA
4
;
Zihan FANG
5
;
Wenpei BAI
6
;
Xinmin LIU
7
;
Hongtian LI
8
;
Fengmei LIAN
9
;
Wei ZHANG
10
;
Lihua QIN
11
;
Min SHANG
12
;
Ailuan LAI
13
;
Xiuxiang TENG
14
;
Mei MO
15
;
Xiaoxiao ZHANG
15
;
Linhua ZHAO
1
Author Information
1. Institute of Metabolic Diseases，Guang'anmen Hospital，China Academy of Chinese Medical Sciences，Beijing 100053，China
2. China-Japan Friendship Hospital，Beijing 100029，China
3. Xiyuan Hospital of China Academy of Chinese Medical Sciences，Beijing 100091，China
4. Beijing University of Chinese Medicine Third Affiliated Hospital，Beijing 100029，China
5. China National Center for Biotechnology Development，Beijing 100039，China
6. Beijng Shijitan Hospital，Capital Medical University，Beijing 100038，China
7. Guang'anmen Hospital，China Academy of Chinese Medical Sciences，Beijing 100053，China
8. School of Public Health，Peking University，Beijing 100191，China
9. GCP Office of Guang'anmen Hospital，China Academy of Chinese Medical Sciences，Beijing 100053，China
10. Xi'an Hospital of Traditional Chinese Medicine，Xi'an 710021，China
11. School of Basic Medical Sciences Peking University，Beijing 100191，China
12. Beijing Friendship Hospital，Capital Medical University，Beijing 100050，China
13. Fu Xing Hospital，Capital Medical University，Beijing 100045，China
14. Beijing Hospital of Traditional Chinese Medicine，Beijing 100010，China
15. China Association of Chinese Medicine，Beijing 100029，China
- Publication Type:Journal Article
- Keywords:
perimenopausal syndrome;
disease responding specifically;
integrated Chinese and Western medicine;
expert advice;
consensus
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2024;30(21):234-242
- CountryChina
- Language:Chinese
-
Abstract:
Perimenopausal syndrome （MPS）， a common endocrine system disease， is one of the diseases responding specifically to traditional Chinese medicine （TCM）. The China Association of Chinese Medicine organized experts in endocrinology， gynecology， and interdisciplinary fields of both Western and Chinese medicine to discuss the advantages and challenges of diagnosing and treating MPS with Western medicine， TCM， and integrative medicine. Experts at the conference believe that MPS is initiated by estrogen decline and rooted in deficiency， with the pathogenesis being imbalance between Yin and Yang in the kidney. The hormone replacement therapy in Western medicine for menopause can rapidly alleviate related symptoms by quickly restoring the estrogen level and timely detect and delay complications of menopause， whereas such a therapy has certain risks， necessitating close monitoring of adverse reactions. Moreover， the various contraindications and precautions limit the clinical application of the hormone replacement therapy. TCM has advantages in synergistically alleviating symptoms such as hot flashes， sweating， sleep disorders， and emotional abnormalities of MPS without causing obvious adverse reactions. However， its efficacy is slower than the hormone replacement therapy， and the TCM evidence for preventing and treating complications of menopause remains unclear. Three suggestions were proposed for the future development of both Western and TCM for ameliorating MPS. First， an integrated diagnosis and treatment system for MPS with both Western and Chinese medicine should be established. Second， high-quality evidence-based interventions for MPS should be developed with TCM alone or in combination with Western medicine. Third， efforts should be made to promote the new TCM drug development and the interdisciplinary cooperation for treating MPS.
